Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
PTI

Bombay High Court tells NGO to approach Collectors on treatment for AIDS patients

The Bombay High Court (Source: File photo)

The Bombay High Court on Thursday directed an NGO to file representation before the Collectors of Sangli and Satara Maharashtra seeking arrangements to be made to provide anti-retroviral therapy (ART) drugs to HIV-positive patients in these two districts.

AIDS drugs prevent sexual transmission of HIV in gay men 

The High Court direction came after it was informed that HIV-infected persons from these two districts were unable to travel to Mumbai for treatment in view of the coronavirus-induced lockdown in the State. The Sangli-based NGO, Veshya AIDS Muquabla Parishad, works for HIV-positive persons.

India has highest number of children and adolescents living with HIV in South Asia: UNICEF report  

A Bench of Justice K.K. Tated was hearing an application filed by the NGO seeking providing anti-retroviral treatment drugs to HIV-positive persons in Sangli and Satara in view of inter-city travel restrictions imposed as part of the lockdown enforced to contain coronavirus (COVID-19) spread.

As per the plea, HIV-infected persons are entitled to ART treatment. HIV-positive persons from Sangli and Satara travel once a month to Mumbai to collect their dosage of ART medication, the plea said. However, this is no longer possible due to the stoppage of inter-city transport facilities, it added.

The plea sought for arrangements to be made so that the medications are made available to HIV-positive persons in their own districts. Justice Tated directed the NGO to file representation before the Collectors of the two districts and asked them to decide on the request expeditiously. ART is the only known treatment that inhibits HIV.

The drug slows down the replication of HIV and immune deterioration is delayed leading to an improvement in survival and quality of life in patients.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.